PRMT5 and prostate carcinoma: Aside from phosphorylation, a study showed that the E3 ubiquitin ligase CHIP negatively regulates PRMT5 expression by promoting PRMT5 degradation through K48-linked ubiquitination in the presence of the HSP90 inhibitor 17-AAG in prostate cancer cells [43].